(19)

(11)

EP 4 740 210 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24840329.7 (22) Date of filing: 05.07.2024

(51) International Patent Classification (IPC):  G16B 20/20(2019.01) C12Q 1/6827(2018.01) C40B 40/06(2006.01) A61P 35/00(2006.01) C12Q 1/6886(2018.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; C12Q 1/6886; G16B 20/20; C12Q 2600/156; G16H 50/30 (86) International application number: PCT/US2024/036902 (87) International publication number: WO 2025/014806 (16.01.2025 Gazette 2025/03)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 07.07.2023 US 202363525534 P (71) Applicant: Myriad Genetics, Inc. Salt Lake City, UT 84108 (US)	(72) Inventors: HUGHES, Elisha Salt Lake City, Utah 84108 (US) GUTIN, Alexander Salt Lake City, Utah 84108 (US) PRUSS, Dmitry Salt Lake City, Utah 84108 (US) SIMMONS, Timothy Salt Lake City, Utah 84108 (US) (74) Representative: Hoffmann Eitle  Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München 81925 München (DE)